Michael Sharland MD

Professor Michel Sharland is a leading expert in antimicrobial prescribing, resistance, and healthcare-associated infection in children. He is the lead clinical advisor for the neonatal and pediatric program of the Global Antibiotic Research and Development Partnership (GARDP) and Vice-Chair and AMR lead of the Penta Foundation, a global Paediatric Infectious Diseases research network.

Sharland previously Chaired the Department of Health’s Expert Advisory Committee of Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI). He has been an advisor for the WHO for many years. He is a member of the Expert Committee on the Selection and Use of Essential Medicines and Chair of the Antibiotic Working Group of the EML/EMLc, assisting with the development of the Access/Watch/Reserve (AWaRE) grouping of antibiotics and WHO global targets on use. Prof Sharland’s principal research interest is optimizing the use of antimicrobials in children. At St George’s University London, he leads a major program of research including global cohort studies and clinical trials to improve the evidence base for antimicrobial prescribing.